CNBX Pharmaceuticals Inc (CNBX)
0.0112
0.00 (0.00%)
USD |
OTCM |
May 17, 16:00
CNBX Pharmaceuticals Shareholders Equity (Quarterly): -2.358M for Feb. 29, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
February 29, 2024 | -2.358M |
November 30, 2023 | -2.095M |
August 31, 2023 | -2.017M |
May 31, 2023 | -1.909M |
February 28, 2023 | -2.012M |
November 30, 2022 | -1.974M |
August 31, 2022 | -1.632M |
May 31, 2022 | -1.182M |
February 28, 2022 | -0.648M |
November 30, 2021 | 0.6274M |
August 31, 2021 | 1.806M |
May 31, 2021 | 2.332M |
February 28, 2021 | 3.783M |
November 30, 2020 | 1.256M |
August 31, 2020 | 1.764M |
May 31, 2020 | 5.098M |
February 29, 2020 | 3.152M |
November 30, 2019 | 6.021M |
August 31, 2019 | 14.74M |
May 31, 2019 | 19.32M |
February 28, 2019 | 17.97M |
November 30, 2018 | 9.071M |
August 31, 2018 | 2.646M |
May 31, 2018 | 2.636M |
February 28, 2018 | 3.248M |
Date | Value |
---|---|
November 30, 2017 | 2.422M |
August 31, 2017 | 2.939M |
May 31, 2017 | 2.877M |
February 28, 2017 | -0.1779M |
November 30, 2016 | -0.2305M |
August 31, 2016 | -0.4674M |
May 31, 2016 | -0.3989M |
February 29, 2016 | -0.3982M |
November 30, 2015 | 0.1573M |
August 31, 2015 | -0.3096M |
May 31, 2015 | 4.237M |
February 28, 2015 | 4.393M |
November 30, 2014 | 4.42M |
August 31, 2014 | 0.0401M |
May 31, 2014 | -0.0038M |
February 28, 2014 | -0.0499M |
November 30, 2013 | -0.0187M |
August 31, 2013 | -0.1054M |
May 31, 2013 | -0.0735M |
February 28, 2013 | -0.0688M |
November 30, 2012 | -0.0641M |
August 31, 2012 | -0.049M |
May 31, 2012 | -0.0634M |
February 29, 2012 | -0.0594M |
November 30, 2011 | -0.0576M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-2.358M
Minimum
Feb 2024
19.32M
Maximum
May 2019
2.204M
Average
0.9416M
Median
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 0.16M |
Palatin Technologies Inc | 1.579M |
iBio Inc | 9.197M |
Theriva Biologics Inc | 34.12M |
Oragenics Inc | 3.168M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.1639M |
Total Liabilities (Quarterly) | 2.522M |
Debt to Equity Ratio | -0.548 |
Current Ratio | 0.065 |
Net Debt Paydown Yield | 25.21% |